A case of acute localized exanthematous pustulosis following COVID-19 infection
Corresponding Author
Yosuke Arai
Department of Dermatology, Faculty of Medicine, Yamagata University, Yamagata, Japan
Correspondence
Yosuke Arai, Department of Dermatology, Yamagata University Faculty of Medicine, 2-2-2 Iida-Nishi, Yamagata 990-9585, Japan.
Email: [email protected]
Search for more papers by this authorKen Okamura
Department of Dermatology, Faculty of Medicine, Yamagata University, Yamagata, Japan
Search for more papers by this authorToru Saito
Department of Dermatology, Faculty of Medicine, Yamagata University, Yamagata, Japan
Search for more papers by this authorTamio Suzuki
Department of Dermatology, Faculty of Medicine, Yamagata University, Yamagata, Japan
Search for more papers by this authorCorresponding Author
Yosuke Arai
Department of Dermatology, Faculty of Medicine, Yamagata University, Yamagata, Japan
Correspondence
Yosuke Arai, Department of Dermatology, Yamagata University Faculty of Medicine, 2-2-2 Iida-Nishi, Yamagata 990-9585, Japan.
Email: [email protected]
Search for more papers by this authorKen Okamura
Department of Dermatology, Faculty of Medicine, Yamagata University, Yamagata, Japan
Search for more papers by this authorToru Saito
Department of Dermatology, Faculty of Medicine, Yamagata University, Yamagata, Japan
Search for more papers by this authorTamio Suzuki
Department of Dermatology, Faculty of Medicine, Yamagata University, Yamagata, Japan
Search for more papers by this author
REFERENCES
- 1Prange B, Marini A, Kalke A, Hodzic-Avdagic N, Ruzicka T, Hengge UR. Acute localized exanthematous pustulosis (ALEP). J Dtsch Dermatol Ges. 2005; 3: 210–212.
- 2Safa I, Ines L, Noureddine L, Meriem J, Manel N, Belhajali H, et al. Acute localized exanthematous pustulosis: clinical features, pathophysiology, and therapy. Dermatol Ther. 2021; 34:e15087.
- 3Bassetti M, Massone C, Vena A, Dettori S, Conforti C, Giacobbe DR, et al. Skin manifestations in patients with coronavirus disease 2019. Curr Opin Infect Dis. 2022; 35: 88–94.
- 4Bellón T. Mechanisms of severe cutaneous adverse reactions: recent advances. Drug Saf. 2019; 42: 973–992.
- 5Hayakawa J, Takakura H, Mizukawa Y, Shiohara T. COVID-19-related cutaneous manifestations associated with multiple drug sensitization as shown by lymphocyte transformation test. J Eur Acad Dermatol Venereol. 2020; 34: e779–e781.
